Vontobel Holding
AUTL icon

Vontobel Holding’s Autolus Therapeutics AUTL Stock Holding History

Vontobel Holding’s Portfolio AUTL Stock Details AUTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-138,783
Closed -$215K – 1257
2025
Q1 		$215K Sell
138,783
-8,636
-6% -$17.5K ﹤0.01% 1002
2024
Q4 		$346K Sell
147,419
-53,522
-27% -$181K ﹤0.01% 887
2024
Q3 		$729K Sell
200,941
-6,156
-3% -$24.6K ﹤0.01% 671
2024
Q2 		$721K Buy
+207,097
New +$894K ﹤0.01% 669

Other funds holding AUTL

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $39B AUM 18.55% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $26.6M AUM 10.36% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Vontobel Holding's AUTL Position: Q2 2025 in Review

Vontobel Holding sold out of Autolus Therapeutics (AUTL) in Q2 2025, closing a stake of 138,783 shares — an estimated $215K sold.

Vontobel Holding first reported a position in AUTL in Q2 2024 and held it in 4 quarters. The position peaked at $729K in Q3 2024. 94 funds tracked by Wall St. Rank hold AUTL as of Q2 2025.

  • Vontobel Holding reported no remaining Autolus Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Vontobel Holding sold 138,783 Autolus Therapeutics shares in Q2 2025, an estimated $215K.
  • Vontobel Holding first reported a position in Autolus Therapeutics in Q2 2024 and held it in 4 quarters.
  • Vontobel Holding's Autolus Therapeutics position peaked at $729K in Q3 2024.
  • 94 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q2 2025.

Based on Vontobel Holding's 13F filing for Q2 2025, filed 23 Jul 2025.